Clinical Trials Browser

Head and Neck Neoplasms × Chemoradiotherapy × Clear all

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Papillomavirus Infections

NCT05526924 2026-03-04

Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer

Phase 1 Recruiting

30 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT01154920 2025-12-17

Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma

Phase 2 Active not recruiting

128 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT01985984 2025-08-14

OutcomeH&N

Recruiting

1,000 enrolled

Head & Neck

Head and Neck Neoplasms

NCT02469922 2021-07-27

TEmPoRAL

Phase NA Completed

130 enrolled

Head & Neck

Head and Neck Neoplasms

NCT00424255 2014-07-18

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Phase 3 Completed

688 enrolled 19 charts

Head & Neck

Head and Neck Neoplasms

NCT00959387 2014-03-26

Induction Chemotherapy for Advanced Head and Neck Cancer

Phase 2 Completed

60 enrolled

Head & Neck

Head and Neck Neoplasms

NCT00140556 2013-01-18

Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer

Phase EARLY_PHASE1 Completed

28 enrolled 8 charts

Head & Neck

Head and Neck Neoplasms, Pharyngeal Neoplasms, Tonsillar Neoplasms

NCT01301248 2011-05-17

Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck

Phase 2 Unknown

80 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Clinical Trials

(NeoScorch HN)

Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer

Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma

OutcomeH&N

TEmPoRAL

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Induction Chemotherapy for Advanced Head and Neck Cancer

Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer

Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck